RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
SinoMab BioScience Stock

SinoMab BioScience Employees 2024

SinoMab BioScience Employees

112

Ticker

3681.HK

ISIN

HK0000544194

In 2024, SinoMab BioScience employed 112 people, a 0% change from the 112 number of employees in the previous year.

SinoMab BioScience Aktienanalyse

What does SinoMab BioScience do?

SinoMab BioScience Ltd is a Chinese biotechnology company specializing in the research, development, and commercial production of innovative biopharmaceutical products. The company was founded in 2001 and is based in Hong Kong. The company's business model focuses on the development of antibody-based therapies for the treatment of cancer and inflammatory diseases. SinoMab BioScience Ltd collaborates closely with leading biopharmaceutical companies, academic institutions, and research facilities worldwide to develop therapeutics that have the potential to improve patients' lives. The company operates in various sectors, including research and development, production, and distribution of biopharmaceutical products. SinoMab also has its own research and development department dedicated to the discovery and development of antibodies. The company aims to build a pipeline of innovative products that address a wide range of medical needs. Currently, SinoMab BioScience Ltd has a range of product candidates in clinical development targeting the treatment of cancer and inflammatory diseases. One of the key products is the antibody preparation SMM-114, used for the treatment of patients with diffuse large B-cell lymphoma (DLBCL). DLBCL is an aggressive form of lymphoma and represents one of the most common cancers in adults. SMM-114 actively inhibits the proliferation of tumor cells by blocking the protein CXCR4, which is expressed on the surface of cancer cells. Another important product candidate of the company is SMAB022, a monoclonal antibody for the treatment of patients with cutaneous squamous cell carcinoma. This product binds to the Epidermal Growth Factor Receptor (EGFR) protein on the surface of cancer cells and inhibits their proliferation. SinoMab BioScience Ltd also has a manufacturing and distribution department for biopharmaceutical products. The company has a GMP-compliant production facility and offers services such as process development, production and purification procedures, stabilization, and formulation of biopharmaceuticals. In addition, SinoMab BioScience Ltd has developed its own in vitro diagnostic (IVD) test for the detection of human papillomavirus (HPV). This disease is one of the most common sexually transmitted infections and is a serious health problem. The HPV IVD is an innovative test system that enables rapid, accurate, and reliable identification of HPV infections. Research and development is highly valued by the company, and it has established its own R&D department consisting of experienced scientists and engineers. This department focuses on the discovery and development of novel biopharmaceutical products and collaborates closely with academic institutions and research facilities. Furthermore, SinoMab BioScience Ltd has formed partnerships with other leading biopharmaceutical companies to collaborate in exploring and harnessing the potential of antibodies for the treatment of diseases. In conclusion, SinoMab BioScience Ltd is an innovative biotechnology company specializing in the development of novel biopharmaceutical therapies for the treatment of cancer and inflammatory diseases. The company has a strong research and development expertise and has built a pipeline of product candidates with the potential to improve patients' lives. With its wide range of products and services in the manufacturing and distribution of biopharmaceuticals, SinoMab BioScience Ltd has established a strong position in the market. SinoMab BioScience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining SinoMab BioScience's Employee Base

SinoMab BioScience's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding SinoMab BioScience's operational capacity and future potential.

Year-to-Year Comparison

Assessing SinoMab BioScience's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

SinoMab BioScience's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in SinoMab BioScience’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about SinoMab BioScience stock

How many employees does SinoMab BioScience have this year?

SinoMab BioScience has 112 undefined employees this year.

How many employees did SinoMab BioScience have compared to the previous year?

Compared to the previous year, SinoMab BioScience had 0% more employees.

What impact did the number of employees have on the company SinoMab BioScience?

The number of employees has a direct impact on the efficiency and productivity of SinoMab BioScience. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of SinoMab BioScience?

The number of employees can also have an impact on investors of SinoMab BioScience, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of SinoMab BioScience affect the company?

An increase in equity of SinoMab BioScience can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in SinoMab BioScience's equity affect the company?

A reduction in equity of SinoMab BioScience can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of SinoMab BioScience?

Some factors that can influence the equity of SinoMab BioScience include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of SinoMab BioScience so important for investors?

The equity of SinoMab BioScience is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at SinoMab BioScience influence the company?

The number of employees at SinoMab BioScience can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at SinoMab BioScience evolved in recent years?

In recent years, the number of employees at SinoMab BioScience has changed by 0.

How many employees does SinoMab BioScience currently have?

SinoMab BioScience currently has 112 undefined employees.

Why is the number of employees important for investors of SinoMab BioScience?

The number of employees is important for investors of SinoMab BioScience as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can SinoMab BioScience take to change the number of employees?

To change the number of employees, SinoMab BioScience can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does SinoMab BioScience pay?

Over the past 12 months, SinoMab BioScience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, SinoMab BioScience is expected to pay a dividend of 0 CNY.

What is the dividend yield of SinoMab BioScience?

The current dividend yield of SinoMab BioScience is .

When does SinoMab BioScience pay dividends?

SinoMab BioScience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of SinoMab BioScience?

SinoMab BioScience paid dividends every year for the past 0 years.

What is the dividend of SinoMab BioScience?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is SinoMab BioScience located?

SinoMab BioScience is assigned to the 'Health' sector.

Wann musste ich die Aktien von SinoMab BioScience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of SinoMab BioScience from 7/11/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 7/11/2024.

When did SinoMab BioScience pay the last dividend?

The last dividend was paid out on 7/11/2024.

What was the dividend of SinoMab BioScience in the year 2023?

In the year 2023, SinoMab BioScience distributed 0 CNY as dividends.

In which currency does SinoMab BioScience pay out the dividend?

The dividends of SinoMab BioScience are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von SinoMab BioScience

Our stock analysis for SinoMab BioScience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SinoMab BioScience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.